Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis

Clin Pediatr (Phila). 2000 Apr;39(4):213-20. doi: 10.1177/000992280003900404.

Abstract

To evaluate combination therapy of mild to moderate bronchiolitis with bronchiodilators and corticosteroids, we treated 51 young children with first-time wheezing and symptoms of respiratory tract infection with albuterol plus either prednisolone or placebo for 5 days. Disease severity was scored on days 0, 2, 3, and 6. On day 2, prednisolone resulted in significantly lower scores (2.7 +/- 1.4 vs. 4.0 +/- 1.5 in all patients evaluated, p < 0.05) than placebo, whereas there was no detectable difference on day 6, suggesting that addition of prednisolone to albuterol transiently accelerates recovery from bronchiolitis. The clinical significance of this effect needs to be evaluated in further studies.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Albuterol / administration & dosage
  • Albuterol / therapeutic use*
  • Analysis of Variance
  • Bronchiolitis / drug therapy*
  • Bronchiolitis / virology
  • Bronchodilator Agents / administration & dosage
  • Bronchodilator Agents / therapeutic use*
  • Drug Therapy, Combination
  • Evaluation Studies as Topic
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Nebulizers and Vaporizers
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Bronchodilator Agents
  • Glucocorticoids
  • Prednisolone
  • Albuterol